We wish to inform you that the Board of Directors of Asarfi Hospital Limited at its meeting held today i.e. Monday, 11th May, 2026, has inter alia considered and approved the Audited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 16.6 pts less than Nifty Microcap 250 and 17.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Asarfi Hospital Limited reported strong financial performance for FY2026 ended March 31. Standalone revenue from operations grew 42% to Rs 17,320 Lakhs from Rs 12,178 Lakhs. Profit after tax increased 55% to Rs 1,708 Lakhs from Rs 1,098 Lakhs. EPS improved from Rs 5.58 to Rs 8.68 per share. On consolidated basis, revenue was Rs 17,350 Lakhs with PAT of Rs 1,666 Lakhs. The company has only one reportable segment (Hospital). Statutory auditors R.K. Thakkar & Co. issued unmodified opinions on both standalone and consolidated results. Operating cash flow turned positive at Rs 1,909 Lakhs (vs negative Rs 384 Lakhs in FY2025).
The company delivered robust double-digit revenue and PAT growth, indicating strong operational performance. Unmodified auditor opinions with no going concern issues provide clean audit status. Improved cash generation is a positive sign for financial health.